semaglutide help with addiction Patients are already asking about and GLP-1s for treatment. The signal is real. The science is still evolving. As new research emerges, clinicians need more than headlines. They need context The weight-loss drug Wegovy may

Compared with SUSTAIN 6, PIONEER 6 included a greater proportion of patients receiving sodium-glucose co-transporter-2 inhibitors (SGLT2is

The crucial role of balanced nutrition and exercise with weight-loss medications

With its unique "triple agonist" mechanism, it could redefine what is possible for patients with significant weight to lose

136 In addition, acquired astrocytopathies are prominent in hepatic encephalopathy (in which astrocytes lose their homoeostatic capabilities 137 ) and in neuromyelitis optica, in which the astrocyte protein, AQP4 is the subject of autoimmune attack, leading to dysfunction and death of astrocytes resulting in pronounced inflammation and degeneration of neural tissue